Efficacy and safety of the implantable, magnetic resonance imaging-compatible StimRouter neuromodulation system in the treatment of refractory lower urinary tract symptoms in multiple sclerosis patients.
Rosaria SaccoPaolo MainoEva KoetsierGiulio DisantoJulien RenardAlex DigesuClaudio GobbiChiara ZeccaPublished in: European journal of neurology (2023)
StimRouter represents a minimally invasive, magnetic resonance imaging-compatible, self-administered neuromodulation device leading to objective and subjective improvements of OAB symptoms and related QoL in MS patients with refractory LUTS.
Keyphrases
- lower urinary tract symptoms
- magnetic resonance imaging
- multiple sclerosis
- benign prostatic hyperplasia
- minimally invasive
- newly diagnosed
- computed tomography
- mass spectrometry
- sleep quality
- contrast enhanced
- prognostic factors
- ms ms
- white matter
- magnetic resonance
- physical activity
- robot assisted
- replacement therapy